Factual end-of-day data for BIOCON: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 22,45,587 shares was close to the 20-day average.
BIOCON's delivery share of 60.8% was above its 20-day average of 50.2%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
Large-trade volume split: 94,971 shares on the buy side vs 88,546 on the sell side.
Largest single sell-side trade: 4,569 shares at ₹418.35.
| Indicator | Reading (26 Aug 2026) |
|---|---|
| RSI (14) | 47.1 |
| 50-day EMA | ₹419.39 — close is below |
| 200-day EMA | ₹400.17 — close is above |
| SuperTrend (10, 3) | ₹405.79 — close is above the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
BIOCON is a large-cap NSE stock in the Pharma sector (Biotechnology industry), with a market capitalisation of about ₹51,581 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 26 Aug 2026, 60.8% of BIOCON's traded volume was marked for delivery (13,65,829 shares delivered). The 20-day average delivery is 50.2%.
BIOCON closed at ₹417.50 on 26 Aug 2026 (+0.07% vs the previous close).
52-week high ₹447.15, 52-week low ₹337.05. The latest close is -6.63% from the 52-week high.